{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:05:58Z","timestamp":1788923158048,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00482-011-1080-x","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T17:26:56Z","timestamp":1312478816000},"page":"434-439","source":"Crossref","is-referenced-by-count":6,"title":["Erfahrungen mit intrathekaler First-line-Therapie mit Ziconotide bei Patienten mit neuropathischen Gesichtsschmerzen","Experience in treatment of patients with neuropathic facial pain using ziconotide"],"prefix":"10.1007","volume":"25","author":[{"given":"E.A.","family":"Lux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,6]]},"reference":[{"key":"1080_CR1","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) (2008) Leitlinie Anhaltender idiopathischer Gesichtsschmerz. URL: http:\/\/www.leitlinien.net"},{"key":"1080_CR2","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) (2008) Leitlinie Diagnostik neuropathischer Schmerzen. URL: http:\/\/www.leitlinien.net"},{"key":"1080_CR3","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) (2008) Leitlinie Therapie neuropathischer Schmerzen. URL: http:\/\/www.leitlinien.net"},{"key":"1080_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1403.2007.00128.x","volume":"10","author":"Deer","year":"2007","unstructured":"Deer T, Krames ES, Hassenbusch SJ et al (2007) Polyanalgesic consensus conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an international expert panel. Neuromodulation 10:300\u2013328","journal-title":"Neuromodulation"},{"key":"1080_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1525-1403.2007.00141.x","volume":"11","author":"Ellis","year":"2008","unstructured":"Ellis DJ, Dissanayake S, McGuire D et al (2008) Continuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12\u00a0months: a prospective, open-label study. Neuromodulation 11:40\u201349","journal-title":"Neuromodulation"},{"key":"1080_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pain.2005.08.013","volume":"118","author":"Finnerup","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ et al (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:297\u2013301","journal-title":"Pain"},{"key":"1080_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ncpneuro0118","volume":"2","author":"Finnerup","year":"2006","unstructured":"Finnerup NB, Jensen TS (2006) Mechanisms of disease: mechanism-based classification of neuropathic pain \u2013 a critical analysis. Nat Clin Pract Neurol 2:107\u2013115","journal-title":"Nat Clin Pract Neurol"},{"key":"1080_CR8","first-page":"1","volume":"386","author":"Greitz","year":"1993","unstructured":"Greitz D (1993) Cerebrospinal fluid circulation and associated intracranial dynamics. A radiologic investigation using MR imaging and radionuclide cisternography. Acta Radiol Suppl 386:1\u201323","journal-title":"Acta Radiol Suppl"},{"key":"1080_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002508-199003000-00003","volume":"6","author":"Harness","year":"1990","unstructured":"Harness DM, Donlon WC, Eversole LR (1990) Comparison of clinical characteristics in myogenic, TMJ internal derangement and atypical facial pain patients. Clin J Pain 6:4\u201317","journal-title":"Clin J Pain"},{"key":"1080_CR10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1213\/ANE.0b013e3181cfc307","volume":"110","author":"Lux","year":"2010","unstructured":"Lux EA (2010) Case report: successful treatment of a patient with trigeminal neuropathy using ziconotide. Anest Analg 110:1195\u20131197","journal-title":"Anest Analg"},{"key":"1080_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2010.10.007","volume":"152","author":"Maier","year":"2011","unstructured":"Maier CH, Gockel HH, Gruhn K et al (2011) Increased risk of suicide under intrathecal ziconotide treatment? \u2013 A warning. Pain 152:235\u2013237","journal-title":"Pain"},{"key":"1080_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/sa.2000.6787","volume":"19","author":"Mathur","year":"2000","unstructured":"Mathur JG (2000) Ziconotide: a new pharmaceutical class of drug for the management of pain. Sem Anaesth Perioperat Med Pain 19:67\u201375","journal-title":"Sem Anaesth Perioperat Med Pain"},{"key":"1080_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/AJP.0b013e3181fb22f4","volume":"27","author":"Michiels","year":"2011","unstructured":"Michiels WB, McGlthlen GL et al (2011) Trigeminal neuralgia relief with intrathecal ziconotide. Clin J Pain 27:352\u2013354","journal-title":"Clin J Pain"},{"key":"1080_CR14","first-page":"595","volume":"63","author":"Pfaffenrath","year":"1992","unstructured":"Pfaffenrath V, Rath M, Keeser W, Pollmann W (1992) Atypischer Gesichtsschmerz \u2013 die Qualit\u00e4t der IHS-Kriterien und psychometrische Daten. Nervenarzt 63:595\u2013601","journal-title":"Nervenarzt"},{"key":"1080_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","volume":"31","author":"Rauck","year":"2006","unstructured":"Rauck RL, Wallace MS, Leong MS et al (2006) A randomised, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 31:393\u2013406","journal-title":"J Pain Symptom Manage"},{"key":"1080_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2009.00303.x","volume":"9","author":"Rauck","year":"2009","unstructured":"Rauck RL, Wallace MS, Burton AW et al (2009) Intrathecal ziconotide for neuropathic pain: a review. Pain Pract 9:327\u2013337","journal-title":"Pain Pract"},{"key":"1080_CR17","first-page":"913","volume":"51","author":"Remick","year":"1985","unstructured":"Remick RA, Blasbergh B (1985) Psychiatric aspects of atypical facial pain. J Can Dent Ass 51:913\u2013916","journal-title":"J Can Dent Ass"},{"key":"1080_CR18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","volume":"375","author":"Schmidtko","year":"2010","unstructured":"Schmidtko A, L\u00f6tsch J, Freynhagen R, Geisslinger G (2010) Ziconotide for treatment of severe chronic pain. Lancet 375:1569\u20131577","journal-title":"Lancet"},{"key":"1080_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","volume":"291","author":"Staats","year":"2004","unstructured":"Staats PS, Yearwood T, Charapata SG et al (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 291:63\u201370","journal-title":"JAMA"},{"key":"1080_CR20","first-page":"106","volume":"152","author":"Tronnier","year":"2010","unstructured":"Tronnier V, Hofacker W, Illias W et al (2010) Empfehlungen zum klinischen Einsatz von Zikonotid zur intrathekalen Therapie chronischer Schmerzen. MMW 152:106\u2013108","journal-title":"MMW"},{"key":"1080_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s004820170049","volume":"15","author":"T\u00fcrp","year":"2001","unstructured":"T\u00fcrp JC (2001) Odontalgie \u2013 ein wenig bekannter Phantomschmerz. Schmerz 15:59\u201364","journal-title":"Schmerz"},{"key":"1080_CR22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.33588\/rn.4511.2007266","volume":"45","author":"Valia-Vera","year":"2007","unstructured":"Valia-Vera JC, Villanueva VL, Asensio-Samper JM et al (2007) Ziconotide: an innovative alternative for intense chronic neuropathic pain. Rev Neurol 45:665\u2013669","journal-title":"Rev Neurol"},{"key":"1080_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","volume":"9","author":"Wallace","year":"2006","unstructured":"Wallace MS, Charapata SG, Fisher R et al (2006) Intrathecal ziconotide in the treatment of chronic non-malignant pain: a randomised, double-blind, placebo-controlled clinical trial. Neuromodulation 9:75\u201386","journal-title":"Neuromodulation"},{"key":"1080_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/AJP.0b013e3181e017df","volume":"26","author":"Wallace","year":"2010","unstructured":"Wallace MS, Rauck RL, Deer T (2010) Ziconotide combination intrathecal therapy: rationale and evidence. Clin J Pain 26:635\u2013644","journal-title":"Clin J Pain"},{"key":"1080_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2000.tb00134.x","volume":"6","author":"Wang","year":"2005","unstructured":"Wang YX, Bowersox SS (2005) Analgesic properties of ziconotide, a selective blocker of N-type neuronal calcium channels. CNS Drug Rev 6:1\u201320","journal-title":"CNS Drug Rev"},{"key":"1080_CR26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0091270003253349","volume":"43","author":"Wermeling","year":"2003","unstructured":"Wermeling DP, Drass M, Ellis D, Mayo M et al (2003) Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients. J Clin Pharmacol 43:624\u2013636","journal-title":"J Clin Pharmacol"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-011-1080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-011-1080-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-011-1080-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:39:59Z","timestamp":1741412399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-011-1080-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s00482-011-1080-x","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}